Go Pro
→ Gates. Google. The Pentagon. (From Behind the Markets) (Ad)tc pixel Free THRL Stock Alerts

Target Healthcare REIT (THRL) Competitors

Target Healthcare REIT logo
GBX 110.80 +0.04 (+0.04%)
As of 07/13/2026 11:53 AM Eastern
Compare

THRL vs. PHP, AGR, IHR, LABS, and MXF

Should you buy Target Healthcare REIT stock or one of its competitors? MarketBeat compares Target Healthcare REIT with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Target Healthcare REIT include Primary Health Properties (PHP), Assura (AGR), Impact Healthcare REIT (IHR), Life Science REIT (LABS), and Medicx Fund (MXF). These companies are all part of the "reit - healthcare facilities" industry.

How does Target Healthcare REIT compare to Primary Health Properties?

Target Healthcare REIT (LON:THRL) and Primary Health Properties (LON:PHP) are both real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

Target Healthcare REIT presently has a consensus target price of GBX 101, suggesting a potential downside of 8.84%. Primary Health Properties has a consensus target price of GBX 114.20, suggesting a potential upside of 23.06%. Given Primary Health Properties' stronger consensus rating and higher possible upside, analysts plainly believe Primary Health Properties is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Primary Health Properties
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Target Healthcare REIT has higher earnings, but lower revenue than Primary Health Properties. Target Healthcare REIT is trading at a lower price-to-earnings ratio than Primary Health Properties, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M8.21£72.07M£12.578.81
Primary Health Properties£224M10.75-£8.64M£6.6014.06

Target Healthcare REIT has a beta of 0.543, meaning that its share price is 46% less volatile than the broader market. Comparatively, Primary Health Properties has a beta of 0.792, meaning that its share price is 21% less volatile than the broader market.

Target Healthcare REIT has a net margin of 104.45% compared to Primary Health Properties' net margin of 45.95%. Target Healthcare REIT's return on equity of 10.73% beat Primary Health Properties' return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Primary Health Properties 45.95%6.03%3.08%

In the previous week, Primary Health Properties had 2 more articles in the media than Target Healthcare REIT. MarketBeat recorded 3 mentions for Primary Health Properties and 1 mentions for Target Healthcare REIT. Target Healthcare REIT's average media sentiment score of 0.29 beat Primary Health Properties' score of -0.02 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Target Healthcare REIT
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Primary Health Properties
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

49.3% of Target Healthcare REIT shares are owned by institutional investors. Comparatively, 29.3% of Primary Health Properties shares are owned by institutional investors. 0.0% of Target Healthcare REIT shares are owned by insiders. Comparatively, 1.0% of Primary Health Properties shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.3%. Primary Health Properties pays an annual dividend of GBX 7.10 per share and has a dividend yield of 7.7%. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Primary Health Properties pays out 107.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Primary Health Properties beats Target Healthcare REIT on 10 of the 18 factors compared between the two stocks.

How does Target Healthcare REIT compare to Assura?

Target Healthcare REIT (LON:THRL) and Assura (LON:AGR) are both small-cap real estate companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Target Healthcare REIT has a beta of 0.543, indicating that its share price is 46% less volatile than the broader market. Comparatively, Assura has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

Target Healthcare REIT has higher earnings, but lower revenue than Assura. Target Healthcare REIT is trading at a lower price-to-earnings ratio than Assura, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M8.21£72.07M£12.578.81
Assura£183.80M8.39-£34.15M£0.05895.85

Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.3%. Assura pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.1%. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Assura pays out 63.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Target Healthcare REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Target Healthcare REIT had 1 more articles in the media than Assura. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Assura. Target Healthcare REIT's average media sentiment score of 0.29 beat Assura's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Assura Neutral

Target Healthcare REIT has a net margin of 104.45% compared to Assura's net margin of 90.32%. Target Healthcare REIT's return on equity of 10.73% beat Assura's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Assura 90.32%10.66%2.82%

49.3% of Target Healthcare REIT shares are owned by institutional investors. Comparatively, 67.2% of Assura shares are owned by institutional investors. 0.0% of Target Healthcare REIT shares are owned by insiders. Comparatively, 0.9% of Assura shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Target Healthcare REIT currently has a consensus price target of GBX 101, indicating a potential downside of 8.84%. Assura has a consensus price target of GBX 60, indicating a potential upside of 26.37%. Given Assura's stronger consensus rating and higher possible upside, analysts plainly believe Assura is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Assura
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Target Healthcare REIT beats Assura on 10 of the 18 factors compared between the two stocks.

How does Target Healthcare REIT compare to Impact Healthcare REIT?

Target Healthcare REIT (LON:THRL) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Target Healthcare REIT currently has a consensus target price of GBX 101, indicating a potential downside of 8.84%. Given Impact Healthcare REIT's higher probable upside, analysts clearly believe Impact Healthcare REIT is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Impact Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Target Healthcare REIT has higher revenue and earnings than Impact Healthcare REIT. Impact Healthcare REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M8.21£72.07M£12.578.81
Impact Healthcare REIT£53.51M0.00£47.58M£0.11N/A

Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.3%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Target Healthcare REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Target Healthcare REIT has a beta of 0.543, indicating that its share price is 46% less volatile than the broader market. Comparatively, Impact Healthcare REIT has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market.

49.3% of Target Healthcare REIT shares are owned by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are owned by institutional investors. 0.0% of Target Healthcare REIT shares are owned by insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Target Healthcare REIT had 1 more articles in the media than Impact Healthcare REIT. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Impact Healthcare REIT. Target Healthcare REIT's average media sentiment score of 0.29 beat Impact Healthcare REIT's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Impact Healthcare REIT Neutral

Target Healthcare REIT has a net margin of 104.45% compared to Impact Healthcare REIT's net margin of 88.90%. Target Healthcare REIT's return on equity of 10.73% beat Impact Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Impact Healthcare REIT 88.90%9.90%4.30%

Summary

Target Healthcare REIT beats Impact Healthcare REIT on 11 of the 16 factors compared between the two stocks.

How does Target Healthcare REIT compare to Life Science REIT?

Life Science REIT (LON:LABS) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Life Science REIT has a beta of 0.08, suggesting that its stock price is 92% less volatile than the broader market. Comparatively, Target Healthcare REIT has a beta of 0.543, suggesting that its stock price is 46% less volatile than the broader market.

Life Science REIT pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. Target Healthcare REIT pays an annual dividend of GBX 5.92 per share and has a dividend yield of 5.3%. Life Science REIT pays out -11.4% of its earnings in the form of a dividend. Target Healthcare REIT pays out 47.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

25.5% of Life Science REIT shares are owned by institutional investors. Comparatively, 49.3% of Target Healthcare REIT shares are owned by institutional investors. 0.0% of Life Science REIT shares are owned by company insiders. Comparatively, 0.0% of Target Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Target Healthcare REIT had 1 more articles in the media than Life Science REIT. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Life Science REIT. Target Healthcare REIT's average media sentiment score of 0.29 beat Life Science REIT's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the news media.

Company Overall Sentiment
Life Science REIT Neutral
Target Healthcare REIT Neutral

Target Healthcare REIT has a net margin of 104.45% compared to Life Science REIT's net margin of -68.83%. Target Healthcare REIT's return on equity of 10.73% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Life Science REIT-68.83% -5.11% 1.25%
Target Healthcare REIT 104.45%10.73%3.86%

Target Healthcare REIT has a consensus target price of GBX 101, indicating a potential downside of 8.84%. Given Target Healthcare REIT's stronger consensus rating and higher possible upside, analysts clearly believe Target Healthcare REIT is more favorable than Life Science REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Life Science REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Life Science REIT-£22.01M-6.85-£40.62M-£8.80N/A
Target Healthcare REIT£83.69M8.21£72.07M£12.578.81

Summary

Target Healthcare REIT beats Life Science REIT on 16 of the 17 factors compared between the two stocks.

How does Target Healthcare REIT compare to Medicx Fund?

Target Healthcare REIT (LON:THRL) and Medicx Fund (LON:MXF) are both real estate companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

49.3% of Target Healthcare REIT shares are held by institutional investors. 0.0% of Target Healthcare REIT shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Target Healthcare REIT had 1 more articles in the media than Medicx Fund. MarketBeat recorded 1 mentions for Target Healthcare REIT and 0 mentions for Medicx Fund. Target Healthcare REIT's average media sentiment score of 0.29 beat Medicx Fund's score of 0.00 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Neutral
Medicx Fund Neutral

Target Healthcare REIT has a net margin of 104.45% compared to Medicx Fund's net margin of 0.00%. Target Healthcare REIT's return on equity of 10.73% beat Medicx Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.45% 10.73% 3.86%
Medicx Fund N/A N/A N/A

Target Healthcare REIT presently has a consensus target price of GBX 101, suggesting a potential downside of 8.84%. Given Medicx Fund's higher possible upside, analysts plainly believe Medicx Fund is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Medicx Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Target Healthcare REIT has higher revenue and earnings than Medicx Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£83.69M8.21£72.07M£12.578.81
Medicx FundN/AN/AN/AN/AN/A

Summary

Target Healthcare REIT beats Medicx Fund on 9 of the 10 factors compared between the two stocks.

Get Target Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THRL vs. The Competition

Export
MetricTarget Healthcare REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£687.22M£2.27B£2.00B£2.85B
Dividend Yield5.41%7.07%7.23%6.16%
P/E Ratio8.81114.8429.99368.18
Price / Sales8.21549.10408.9384,612.72
Price / Cash14.3749.2268.3627.87
Price / Book1.001.651.387.49
Net Income£72.07M-£74.43M-£125.49M£5.89B
7 Day PerformanceN/A-0.56%-0.40%-0.19%
1 Month Performance2.16%2.30%-0.14%-1.00%
1 Year Performance10.91%12.79%-1.35%61.67%

Target Healthcare REIT Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THRL
Target Healthcare REIT
1.5429 of 5 stars		GBX 110.80
+0.0%		GBX 101
-8.8%		+11.6%£687.22M£83.69M8.81N/A
PHP
Primary Health Properties
3.7936 of 5 stars		GBX 93.90
-0.4%		GBX 114.20
+21.6%		-3.4%£2.44B£224M14.2358
AGR
Assura
N/AGBX 47.48
+0.4%		GBX 60
+26.4%		-5.0%£1.54B£183.80M895.8584
IHR
Impact Healthcare REIT
N/AN/AN/AN/A£361.75M£53.51M793.64N/A
LABS
Life Science REIT
N/AGBX 43.10
flat		N/AN/A£150.85M-£22.01MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:THRL) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel
Forget SpaceX, this is Elon’s Next Breakthrough
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel
When I found Rolls-Royce under $2, most people thought I was crazy
In 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...
Monument Traders Alliance | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel